Author Title Type [ Year(Desc)]
Filters: Author is Wang, Tao  [Clear All Filters]
Jindra PT, Conway SE, Ricklefs SM, Porcella SF, Anzick SL, Haagenson M, Wang T, Spellman S, Milford E, Kraft P, et al. Analysis of a genetic polymorphism in the costimulatory molecule TNFSF4 with HSCT outcomes. Biol Blood Marrow Transplant. 2015.
Zhong B, Wang T, Zou J, Zheng F, Huang R, Zheng X, Yang W, Chen Z. Association of the intermediate filament nestin with cancer stage: a meta-analysis based on 223 positive/high nestin cases and 460 negative/low case-free controls. Oncotarget. 2015.
Wang T, Gantier MP, Xiang D, Bean AG, Bruce M, Zhou S-F, Khasraw M, Ward A, Wang L, Wei MQ, et al. EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model. Theranostics. 2015;5(12):1456-72.
Xiang D, Shigdar S, Qiao G, Wang T, Kouzani AZ, Zhou S-F, Kong L, Li Y, Pu C, Duan W. Nucleic Acid Aptamer-Guided Cancer Therapeutics and Diagnostics: the Next Generation of Cancer Medicine. Theranostics. 2015;5(1):23-42.
Nakasone H, Sahaf B, Tian L, Wang T, Haagenson MD, Schoenrock K, Perloff S, Ryan CE, Wu F, Spellman SR, et al. Pre-sensitization to HY-antigens in female donors prior to transplant is not associated with male recipient post-transplant HY-antibody development nor clinical outcomes. Haematologica. 2015.
Chen Y-F, Wang Y-Y, Wang J-J, Gao X-N, Wang X-L, Zhao S-W, Wang T, Dou H-Y. [Research Progress on Muscle-derived Stem Cells Capable of Hematopoiesis]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015;23(5):1523-1526.
Zhao L, Yang Y, Zhou P, Ma H, Zhao X, He X, Wang T, Zhang J, Liu Y, Zhang T. Targeting CD133high Colorectal Cancer Cells In Vitro and In Vivo With an Asymmetric Bispecific Antibody. J Immunother. 2015;38(6):217-228.